MRE-269 T3S2007
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MRE-269 is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 is used for the treatment of pulmonary arterial hypertension. MRE-269 is an active metabolite of Selexipag (S253150).
CAS nr:
475085-57-5
Purity:
98%
Molecular Weight:
419,52
SMILES:
CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1
Formula:
C25H29N3O3
Pathway:
GPCR/G Protein,Immunology/Inflammation
Target:
Prostaglandin Receptor,Prostaglandin Receptor
